At AU$2.84, Is Nanosonics Limited (ASX:NAN) Worth Looking At Closely?
RBC Capital Keeps Their Hold Rating on Nanosonics Limited (NNCSF)
Analysts Offer Insights on Healthcare Companies: Amylyx Pharmaceuticals Inc (AMLX) and Nanosonics Limited (OtherNNCSF)
Nanosonics Limited (ASX:NAN) Just Reported Earnings, And Analysts Cut Their Target Price
Nanosonics Limited (NNCSF) Gets a Hold From RBC Capital
Analysts' Opinions Are Mixed on These Healthcare Stocks: Apellis Pharmaceuticals (APLS), Dexcom (DXCM) and Nanosonics Limited (OtherNNCSF)
Citi Keeps Their Sell Rating on Nanosonics Limited (NNCSF)
Nanosonics Limited (ASX:NAN) Is Largely Controlled by Institutional Shareholders Who Own 63% of the Company
A Look At The Intrinsic Value Of Nanosonics Limited (ASX:NAN)
Should Weakness in Nanosonics Limited's (ASX:NAN) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Shareholders Will Probably Hold Off On Increasing Nanosonics Limited's (ASX:NAN) CEO Compensation For The Time Being
Nanosonics Limited (NNCSF) Gets a Buy From Wilsons
Bell Potter Upgrades Nanosonics Limited (NNCSF) to a Hold
Citi Sticks to Their Sell Rating for Nanosonics Limited (NNCSF)
Nanosonics Reports FY Results
Goldman Sachs Remains a Sell on Nanosonics Limited (NNCSF)
RBC Capital Sticks to Their Hold Rating for Nanosonics Limited (NNCSF)
With 58% Ownership, Nanosonics Limited (ASX:NAN) Boasts of Strong Institutional Backing
Bell Potter Sticks to Their Sell Rating for Nanosonics Limited (NNCSF)
Analysts' Top Healthcare Picks: Neuren Pharmaceuticals Limited (NURPF), Nanosonics Limited (NNCSF)
No Data